ZORAN ZDRAVESKI, Title: Secretary and Chief Legal and Technology Op at Dianthus Therapeutics, holds 4.72K shares in TScan Therapeutics (Ticker: TCRX), holds 128.01K shares in Dianthus Therapeutics (Ticker: DNTH).
What is the percentage of profitable transactions made by ZORAN ZDRAVESKI?
The percentage of profitable transactions made by ZORAN ZDRAVESKI is 0%.
What is the average return per transaction made by ZORAN ZDRAVESKI?
The average return per transaction made by ZORAN ZDRAVESKI is -35.50%.
What stocks does ZORAN ZDRAVESKI hold?
ZORAN ZDRAVESKI holds: DNTH, TCRX stocks.
What was ZORAN ZDRAVESKI’s latest transaction?
ZORAN ZDRAVESKI latest transaction was an Uninformative Buy of $531.52K.
What was ZORAN ZDRAVESKI's most profitable transaction?
ZORAN ZDRAVESKI’s most profitable transaction was an Informative Sell of TCRX stock on August 27, 2024. The return on the trade was -4.50%.
What is ZORAN ZDRAVESKI's role in Dianthus Therapeutics?
ZORAN ZDRAVESKI's role in Dianthus Therapeutics is Title: Secretary and Chief Legal and Technology Op.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.